CDK4 and neoplasm: To assess the potential CDK4/6i sensitivity of MKShi/ERSlo tumours, we examined the Rb loss-of-function signature (RBsig), which consists of E2F-associated genes and has been linked to poor prognosis and resistance to palbociclib [23].